Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases

NCT00204581 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Tuebingen